Anti-Transforming Growth Factor Beta 3 (TGFb3) Polyclonal Antibody Homo sapiens (Human) Protein, Antibody, Assaykit, Service

TGF-B3; LAP; Latency-associated peptide

No quotes Distributors
Overview
Properties
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Excitation Laser
  • Vol. per test
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Anti-Transforming Growth Factor Beta 3 (TGFb3) Polyclonal Antibody Packages (Simulation)
  • Anti-Transforming Growth Factor Beta 3 (TGFb3) Polyclonal Antibody Packages (Simulation)
  • Anti-Transforming Growth Factor Beta 3 (TGFb3) Polyclonal Antibody Human A549 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-human TGFb3 Polyclonal Antibody (Catalog FAB949Hu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Usage

Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Giveaways

Citations

  • A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic ApproachesPlosone: Source
  • The immunomodulating effect of seminal plasma on T cellsPubMed: 25799173
  • Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroidspubmed:27743697
  • New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiationpubmed:28087378
  • Transforme edici büyüme faktörü-beta-1 nötralizan antikoru ve transforme edici büyüme faktörü-beta-3'ün trakeal darlık gelişimi üzerine etkileri10.5606/tgkdc.dergisi.2017.14302
  • Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroidsPubmed:29525690
  • TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degenerationPubmed:29795291
  • The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosisPubmed: 30367890
  • Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose TissuePubmed: 30332637
  • Temporal TGF-β Supergene Family Signalling Cues Modulating Tissue Morphogenesis: Chondrogenesis within a Muscle Tissue Model?Pubmed: 32660137
  • Limited added value of negative pressure wound therapy compared to calcium alginate dressings for second intention healing in a non©\contaminated and?¡­34115409
  • Nanoparticles and Nanostructured Films with TGF-β3: Preparation, Characterization, and Efficacy34378118

Recommend products